News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
777,113 Results
Type
Article (51847)
Company Profile (328)
Press Release (724921)
Multimedia
Podcasts (135)
Webinars (23)
Section
Business (214213)
Career Advice (2399)
Deals (36904)
Drug Delivery (154)
Drug Development (83951)
Employer Resources (182)
FDA (17305)
Job Trends (15892)
News (362429)
Policy (35318)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Genetown Elite (4)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (6)
Academia (2893)
Academic (2)
Accelerated approval (51)
Adcomms (31)
Allergies (184)
Alliances (52303)
ALS (217)
Alzheimer's disease (1888)
Antibody-drug conjugate (ADC) (493)
Approvals (17691)
Artificial intelligence (739)
Autoimmune disease (317)
Automation (59)
Bankruptcy (370)
Best Places to Work (12298)
BIOSECURE Act (21)
Biosimilars (237)
Biotechnology (198)
Bladder cancer (199)
Brain cancer (78)
Breast cancer (791)
Cancer (6114)
Cardiovascular disease (510)
Career advice (2045)
Career pathing (48)
CAR-T (349)
CDC (72)
Celiac Disease (3)
Cell therapy (952)
Cervical cancer (50)
Clinical research (72812)
Collaboration (2220)
Company closure (6)
Compensation (1435)
Complete response letters (83)
COVID-19 (2948)
CRISPR (118)
C-suite (1211)
Cystic fibrosis (160)
Data (8247)
Decentralized trials (3)
Denatured (43)
Depression (178)
Dermatology (93)
Diabetes (623)
Diagnostics (7358)
Digital health (61)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (348)
Drug pricing (226)
Drug shortages (32)
Duchenne muscular dystrophy (299)
Earnings (94851)
Editorial (75)
Employer branding (23)
Employer resources (159)
Events (129384)
Executive appointments (1148)
FDA (21192)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (36)
Funding (1839)
Gene editing (255)
Generative AI (67)
Gene therapy (767)
GLP-1 (1136)
Government (5346)
Grass and pollen (7)
Guidances (412)
Healthcare (20711)
HIV (86)
Huntington's disease (56)
IgA nephropathy (101)
Immunology and inflammation (312)
Immuno-oncology (100)
Indications (198)
Infectious disease (3326)
Inflammatory bowel disease (225)
Inflation Reduction Act (17)
Influenza (146)
Intellectual property (302)
Interviews (380)
IPO (17103)
IRA (54)
Job creations (3917)
Job search strategy (1712)
JPM (69)
Kidney cancer (20)
Labor market (106)
Layoffs (603)
Leadership (45)
Legal (8549)
Liver cancer (107)
Longevity (35)
Lung cancer (798)
Lymphoma (442)
Machine learning (62)
Management (62)
Manufacturing (1112)
MASH (211)
Medical device (14692)
Medtech (14831)
Mergers & acquisitions (21092)
Metabolic disorders (1617)
mRNA (240)
Multiple sclerosis (195)
NASH (18)
Neurodegenerative disease (456)
Neuropsychiatric disorders (113)
Neuroscience (3490)
Neurotech (1)
NextGen: Class of 2026 (7172)
Non-profit (4994)
Now hiring (79)
Obesity (760)
Opinion (328)
Ovarian cancer (232)
Pain (268)
Pancreatic cancer (320)
Parkinson's disease (390)
Partnered (34)
Patents (616)
Patient recruitment (708)
Peanut (65)
People (62636)
Pharmaceutical (72)
Pharmacy benefit managers (36)
Phase 1 (22790)
Phase 2 (31931)
Phase 3 (23770)
Pipeline (9205)
Policy (361)
Postmarket research (2777)
Preclinical (9691)
Press Release (71)
Prostate cancer (320)
Psychedelics (61)
Radiopharmaceuticals (351)
Rare diseases (1146)
Real estate (6326)
Recruiting (73)
Regulatory (27119)
Reports (57)
Research institute (2650)
Resumes & cover letters (397)
Rett syndrome (39)
RNA editing (22)
RSV (94)
Schizophrenia (184)
Series A (311)
Series B (227)
Service/supplier (13)
Sickle cell disease (121)
Special edition (29)
Spinal muscular atrophy (175)
Sponsored (52)
Startups (3901)
State (2)
Stomach cancer (20)
Supply chain (136)
Tariffs (92)
The Weekly (90)
Vaccines (1231)
Venture capital (117)
Weight loss (502)
Women's health (135)
Worklife (23)
Date
Last 7 days (631)
Last 30 days (3241)
Last 365 days (31218)
2026 (14204)
2025 (31421)
2024 (36553)
2023 (41490)
2022 (52753)
2021 (57488)
2020 (56457)
2019 (49713)
2018 (37642)
2017 (33869)
2016 (33956)
2015 (39983)
2014 (33718)
2013 (28769)
2012 (30905)
2011 (31547)
2010 (29737)
Location
Africa (889)
Alabama (98)
Alaska (7)
Arizona (373)
Arkansas (15)
Asia (42994)
Australia (7167)
California (13816)
Canada (3880)
China (1430)
Colorado (591)
Connecticut (612)
Delaware (420)
Europe (95707)
Florida (2076)
Georgia (453)
Hawaii (4)
Idaho (69)
Illinois (1142)
India (96)
Indiana (633)
Iowa (24)
Japan (569)
Kansas (138)
Kentucky (53)
Louisiana (48)
Maine (89)
Maryland (1674)
Massachusetts (9985)
Michigan (400)
Minnesota (765)
Mississippi (6)
Missouri (151)
Montana (35)
Nebraska (29)
Nevada (151)
New Hampshire (90)
New Jersey (3660)
New Mexico (30)
New York (3642)
North Carolina (1816)
North Dakota (10)
Northern California (6920)
Ohio (428)
Oklahoma (25)
Oregon (43)
Pennsylvania (2749)
Puerto Rico (29)
Rhode Island (50)
South America (1262)
South Carolina (88)
South Dakota (2)
Southern California (5464)
Tennessee (219)
Texas (2221)
United States (49183)
Utah (416)
Vermont (1)
Virginia (341)
Washington D.C. (85)
Washington State (1119)
West Virginia (4)
Wisconsin (147)
Wyoming (2)
777,113 Results for "health net inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES INTO THE FIRST QUARTER OF 2026 NET REVENUE +4.9%, EBITDA(1) +5.0%, ADJUSTED NET INCOME(2) +7.2%
May 13, 2026
·
23 min read
Press Releases
Oncotelic Therapeutics Reports FY 2025 Results Highlighting $249M Net Income and JV Pipeline Progress
April 16, 2026
·
13 min read
Press Releases
Progyny, Inc. to Present at BofA Securities 2026 Health Care Conference
May 11, 2026
·
1 min read
Press Releases
OS Therapies Completes $5.25M Registered Direct Offering Primarily with Pre-Existing High-Net-Worth Investors
• Company expects approximately $2 million in non-dilutive VAT refunds from wholly owned U.K. subsidiary in 2Q-26 • Company expects to receive approximately $2 million in non-dilutive R&D tax credits repayable to the company in cash from its U.K. subsidiary in 2H-26 • Offering net proceeds, together with funds expected to be received via U.K. subsidiary, expected to provide cash runway into 2027 • Company expects to receive approvals in the U.S., U.K. and Europe for OST-HER2 in the prevention of delay of recurrent, fully resected, pulmonary metastatic osteosarcoma in the second half of 2026
April 2, 2026
·
7 min read
Press Releases
Hyperion DeFi Reports 1Q 2026 Financial Results with Record Net Income and Raises Guidance for Full Year 2026
May 14, 2026
·
43 min read
Press Releases
Niagen Bioscience Reports 30% Year-Over-Year Net Sales Increase to $129.4 million, 103% Net Income Increase to $17.4 million or $0.22 Basic EPS in 2025
March 5, 2026
·
19 min read
Press Releases
DaVita Inc. to Participate in the BofA Securities 2026 Health Care Conference
May 7, 2026
·
1 min read
Press Releases
Mesoblast Reports Ryoncil® Net Revenues of US$30.3m and Improved Net Operating Cash Spend for the Quarter to US$4.1 Million
April 29, 2026
·
8 min read
Press Releases
Fosun Pharma Announces Q1 2026 Results: Net Profit Attributable to Shareholders After Deducting Non-Recurring Gains and Losses Increased by 21.96% YoY, With Strong Pipeline Execution
April 28, 2026
·
9 min read
Press Releases
Jaguar Health Reports Third Quarter 2025 Financials: Net Q3 2025 Revenue Up Approximately 4% Versus Net Q2 2025 Revenue
November 18, 2025
·
11 min read
1 of 77,712
Next
